Medical Care
Global Clinical Biomarker Testing Market Research Report 2025
- Jul 08, 25
- ID: 348384
- Pages: 73
- Figures: 72
- Views: 37
The global market for Clinical Biomarker Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
This report aims to provide a comprehensive presentation of the global market for Clinical Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Biomarker Testing.
The Clinical Biomarker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Biomarker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
Segment by Type
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Biomarker Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
This report aims to provide a comprehensive presentation of the global market for Clinical Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Biomarker Testing.
The Clinical Biomarker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Biomarker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
Segment by Type
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Biomarker Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer
1.2.3 Metabolism
1.2.4 Infectious Disease
1.2.5 Cardiology
1.2.6 Neurology
1.2.7 Immunological Disease
1.3 Market by Application
1.3.1 Global Clinical Biomarker Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarker Testing Market Perspective (2020-2031)
2.2 Global Clinical Biomarker Testing Growth Trends by Region
2.2.1 Global Clinical Biomarker Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Biomarker Testing Historic Market Size by Region (2020-2025)
2.2.3 Clinical Biomarker Testing Forecasted Market Size by Region (2026-2031)
2.3 Clinical Biomarker Testing Market Dynamics
2.3.1 Clinical Biomarker Testing Industry Trends
2.3.2 Clinical Biomarker Testing Market Drivers
2.3.3 Clinical Biomarker Testing Market Challenges
2.3.4 Clinical Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarker Testing Players by Revenue
3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2020-2025)
3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Biomarker Testing Revenue
3.4 Global Clinical Biomarker Testing Market Concentration Ratio
3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2024
3.5 Global Key Players of Clinical Biomarker Testing Head office and Area Served
3.6 Global Key Players of Clinical Biomarker Testing, Product and Application
3.7 Global Key Players of Clinical Biomarker Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarker Testing Breakdown Data by Type
4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2020-2025)
4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2026-2031)
5 Clinical Biomarker Testing Breakdown Data by Application
5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2020-2025)
5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Biomarker Testing Market Size (2020-2031)
6.2 North America Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Biomarker Testing Market Size by Country (2020-2025)
6.4 North America Clinical Biomarker Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Biomarker Testing Market Size (2020-2031)
7.2 Europe Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Biomarker Testing Market Size by Country (2020-2025)
7.4 Europe Clinical Biomarker Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2020-2031)
8.2 Asia-Pacific Clinical Biomarker Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Biomarker Testing Market Size (2020-2031)
9.2 Latin America Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Biomarker Testing Market Size by Country (2020-2025)
9.4 Latin America Clinical Biomarker Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2020-2031)
10.2 Middle East & Africa Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Details
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2020-2025)
11.2.5 AbbVie Inc. Recent Development
11.3 Adaptive Biotechnologies
11.3.1 Adaptive Biotechnologies Company Details
11.3.2 Adaptive Biotechnologies Business Overview
11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2020-2025)
11.3.5 Adaptive Biotechnologies Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Clinical Biomarker Testing Introduction
11.5.4 BD Revenue in Clinical Biomarker Testing Business (2020-2025)
11.5.5 BD Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2020-2025)
11.6.5 Becton Dickinson Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Merck and Co.
11.9.1 Merck and Co. Company Details
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2020-2025)
11.9.5 Merck and Co. Recent Development
11.10 Thermofisher Scientific
11.10.1 Thermofisher Scientific Company Details
11.10.2 Thermofisher Scientific Business Overview
11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2020-2025)
11.10.5 Thermofisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer
1.2.3 Metabolism
1.2.4 Infectious Disease
1.2.5 Cardiology
1.2.6 Neurology
1.2.7 Immunological Disease
1.3 Market by Application
1.3.1 Global Clinical Biomarker Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarker Testing Market Perspective (2020-2031)
2.2 Global Clinical Biomarker Testing Growth Trends by Region
2.2.1 Global Clinical Biomarker Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Biomarker Testing Historic Market Size by Region (2020-2025)
2.2.3 Clinical Biomarker Testing Forecasted Market Size by Region (2026-2031)
2.3 Clinical Biomarker Testing Market Dynamics
2.3.1 Clinical Biomarker Testing Industry Trends
2.3.2 Clinical Biomarker Testing Market Drivers
2.3.3 Clinical Biomarker Testing Market Challenges
2.3.4 Clinical Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarker Testing Players by Revenue
3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2020-2025)
3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Biomarker Testing Revenue
3.4 Global Clinical Biomarker Testing Market Concentration Ratio
3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2024
3.5 Global Key Players of Clinical Biomarker Testing Head office and Area Served
3.6 Global Key Players of Clinical Biomarker Testing, Product and Application
3.7 Global Key Players of Clinical Biomarker Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarker Testing Breakdown Data by Type
4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2020-2025)
4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2026-2031)
5 Clinical Biomarker Testing Breakdown Data by Application
5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2020-2025)
5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Biomarker Testing Market Size (2020-2031)
6.2 North America Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Biomarker Testing Market Size by Country (2020-2025)
6.4 North America Clinical Biomarker Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Biomarker Testing Market Size (2020-2031)
7.2 Europe Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Biomarker Testing Market Size by Country (2020-2025)
7.4 Europe Clinical Biomarker Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2020-2031)
8.2 Asia-Pacific Clinical Biomarker Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Biomarker Testing Market Size (2020-2031)
9.2 Latin America Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Biomarker Testing Market Size by Country (2020-2025)
9.4 Latin America Clinical Biomarker Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2020-2031)
10.2 Middle East & Africa Clinical Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Details
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2020-2025)
11.2.5 AbbVie Inc. Recent Development
11.3 Adaptive Biotechnologies
11.3.1 Adaptive Biotechnologies Company Details
11.3.2 Adaptive Biotechnologies Business Overview
11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2020-2025)
11.3.5 Adaptive Biotechnologies Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Clinical Biomarker Testing Introduction
11.5.4 BD Revenue in Clinical Biomarker Testing Business (2020-2025)
11.5.5 BD Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2020-2025)
11.6.5 Becton Dickinson Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Merck and Co.
11.9.1 Merck and Co. Company Details
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2020-2025)
11.9.5 Merck and Co. Recent Development
11.10 Thermofisher Scientific
11.10.1 Thermofisher Scientific Company Details
11.10.2 Thermofisher Scientific Business Overview
11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2020-2025)
11.10.5 Thermofisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Clinical Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cancer
Table 3. Key Players of Metabolism
Table 4. Key Players of Infectious Disease
Table 5. Key Players of Cardiology
Table 6. Key Players of Neurology
Table 7. Key Players of Immunological Disease
Table 8. Global Clinical Biomarker Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Clinical Biomarker Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Clinical Biomarker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Clinical Biomarker Testing Market Share by Region (2020-2025)
Table 12. Global Clinical Biomarker Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Clinical Biomarker Testing Market Share by Region (2026-2031)
Table 14. Clinical Biomarker Testing Market Trends
Table 15. Clinical Biomarker Testing Market Drivers
Table 16. Clinical Biomarker Testing Market Challenges
Table 17. Clinical Biomarker Testing Market Restraints
Table 18. Global Clinical Biomarker Testing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Clinical Biomarker Testing Market Share by Players (2020-2025)
Table 20. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2024)
Table 21. Ranking of Global Top Clinical Biomarker Testing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Clinical Biomarker Testing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Clinical Biomarker Testing, Headquarters and Area Served
Table 24. Global Key Players of Clinical Biomarker Testing, Product and Application
Table 25. Global Key Players of Clinical Biomarker Testing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Clinical Biomarker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Clinical Biomarker Testing Revenue Market Share by Type (2020-2025)
Table 29. Global Clinical Biomarker Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Clinical Biomarker Testing Revenue Market Share by Type (2026-2031)
Table 31. Global Clinical Biomarker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Clinical Biomarker Testing Revenue Market Share by Application (2020-2025)
Table 33. Global Clinical Biomarker Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Clinical Biomarker Testing Revenue Market Share by Application (2026-2031)
Table 35. North America Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Clinical Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 50. Abbott Laboratories Company Details
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories Clinical Biomarker Testing Product
Table 53. Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. AbbVie Inc. Company Details
Table 56. AbbVie Inc. Business Overview
Table 57. AbbVie Inc. Clinical Biomarker Testing Product
Table 58. AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 59. AbbVie Inc. Recent Development
Table 60. Adaptive Biotechnologies Company Details
Table 61. Adaptive Biotechnologies Business Overview
Table 62. Adaptive Biotechnologies Clinical Biomarker Testing Product
Table 63. Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 64. Adaptive Biotechnologies Recent Development
Table 65. Agilent Technologies Company Details
Table 66. Agilent Technologies Business Overview
Table 67. Agilent Technologies Clinical Biomarker Testing Product
Table 68. Agilent Technologies Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 69. Agilent Technologies Recent Development
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Clinical Biomarker Testing Product
Table 73. BD Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 74. BD Recent Development
Table 75. Becton Dickinson Company Details
Table 76. Becton Dickinson Business Overview
Table 77. Becton Dickinson Clinical Biomarker Testing Product
Table 78. Becton Dickinson Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 79. Becton Dickinson Recent Development
Table 80. Bio-Rad Laboratories Company Details
Table 81. Bio-Rad Laboratories Business Overview
Table 82. Bio-Rad Laboratories Clinical Biomarker Testing Product
Table 83. Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 84. Bio-Rad Laboratories Recent Development
Table 85. Danaher Corporation Company Details
Table 86. Danaher Corporation Business Overview
Table 87. Danaher Corporation Clinical Biomarker Testing Product
Table 88. Danaher Corporation Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 89. Danaher Corporation Recent Development
Table 90. Merck and Co. Company Details
Table 91. Merck and Co. Business Overview
Table 92. Merck and Co. Clinical Biomarker Testing Product
Table 93. Merck and Co. Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 94. Merck and Co. Recent Development
Table 95. Thermofisher Scientific Company Details
Table 96. Thermofisher Scientific Business Overview
Table 97. Thermofisher Scientific Clinical Biomarker Testing Product
Table 98. Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 99. Thermofisher Scientific Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Clinical Biomarker Testing Picture
Figure 2. Global Clinical Biomarker Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Biomarker Testing Market Share by Type: 2024 VS 2031
Figure 4. Cancer Features
Figure 5. Metabolism Features
Figure 6. Infectious Disease Features
Figure 7. Cardiology Features
Figure 8. Neurology Features
Figure 9. Immunological Disease Features
Figure 10. Global Clinical Biomarker Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Clinical Biomarker Testing Market Share by Application: 2024 VS 2031
Figure 12. Drug Discovery Case Studies
Figure 13. Nutrigenomics Case Studies
Figure 14. Toxicology Testing Case Studies
Figure 15. Personalized Medicine Case Studies
Figure 16. Functional Genomics Case Studies
Figure 17. Clinical Biomarker Testing Report Years Considered
Figure 18. Global Clinical Biomarker Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Clinical Biomarker Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Clinical Biomarker Testing Market Share by Region: 2024 VS 2031
Figure 21. Global Clinical Biomarker Testing Market Share by Players in 2024
Figure 22. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Clinical Biomarker Testing Revenue in 2024
Figure 24. North America Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 26. United States Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 30. Germany Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Clinical Biomarker Testing Market Share by Region (2020-2031)
Figure 38. China Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 46. Mexico Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 50. Turkey Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Abbott Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 54. AbbVie Inc. Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 55. Adaptive Biotechnologies Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 56. Agilent Technologies Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 57. BD Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 58. Becton Dickinson Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 60. Danaher Corporation Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 61. Merck and Co. Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 62. Thermofisher Scientific Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Clinical Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cancer
Table 3. Key Players of Metabolism
Table 4. Key Players of Infectious Disease
Table 5. Key Players of Cardiology
Table 6. Key Players of Neurology
Table 7. Key Players of Immunological Disease
Table 8. Global Clinical Biomarker Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Clinical Biomarker Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Clinical Biomarker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Clinical Biomarker Testing Market Share by Region (2020-2025)
Table 12. Global Clinical Biomarker Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Clinical Biomarker Testing Market Share by Region (2026-2031)
Table 14. Clinical Biomarker Testing Market Trends
Table 15. Clinical Biomarker Testing Market Drivers
Table 16. Clinical Biomarker Testing Market Challenges
Table 17. Clinical Biomarker Testing Market Restraints
Table 18. Global Clinical Biomarker Testing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Clinical Biomarker Testing Market Share by Players (2020-2025)
Table 20. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2024)
Table 21. Ranking of Global Top Clinical Biomarker Testing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Clinical Biomarker Testing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Clinical Biomarker Testing, Headquarters and Area Served
Table 24. Global Key Players of Clinical Biomarker Testing, Product and Application
Table 25. Global Key Players of Clinical Biomarker Testing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Clinical Biomarker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Clinical Biomarker Testing Revenue Market Share by Type (2020-2025)
Table 29. Global Clinical Biomarker Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Clinical Biomarker Testing Revenue Market Share by Type (2026-2031)
Table 31. Global Clinical Biomarker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Clinical Biomarker Testing Revenue Market Share by Application (2020-2025)
Table 33. Global Clinical Biomarker Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Clinical Biomarker Testing Revenue Market Share by Application (2026-2031)
Table 35. North America Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Clinical Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Clinical Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
Table 50. Abbott Laboratories Company Details
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories Clinical Biomarker Testing Product
Table 53. Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. AbbVie Inc. Company Details
Table 56. AbbVie Inc. Business Overview
Table 57. AbbVie Inc. Clinical Biomarker Testing Product
Table 58. AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 59. AbbVie Inc. Recent Development
Table 60. Adaptive Biotechnologies Company Details
Table 61. Adaptive Biotechnologies Business Overview
Table 62. Adaptive Biotechnologies Clinical Biomarker Testing Product
Table 63. Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 64. Adaptive Biotechnologies Recent Development
Table 65. Agilent Technologies Company Details
Table 66. Agilent Technologies Business Overview
Table 67. Agilent Technologies Clinical Biomarker Testing Product
Table 68. Agilent Technologies Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 69. Agilent Technologies Recent Development
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Clinical Biomarker Testing Product
Table 73. BD Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 74. BD Recent Development
Table 75. Becton Dickinson Company Details
Table 76. Becton Dickinson Business Overview
Table 77. Becton Dickinson Clinical Biomarker Testing Product
Table 78. Becton Dickinson Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 79. Becton Dickinson Recent Development
Table 80. Bio-Rad Laboratories Company Details
Table 81. Bio-Rad Laboratories Business Overview
Table 82. Bio-Rad Laboratories Clinical Biomarker Testing Product
Table 83. Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 84. Bio-Rad Laboratories Recent Development
Table 85. Danaher Corporation Company Details
Table 86. Danaher Corporation Business Overview
Table 87. Danaher Corporation Clinical Biomarker Testing Product
Table 88. Danaher Corporation Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 89. Danaher Corporation Recent Development
Table 90. Merck and Co. Company Details
Table 91. Merck and Co. Business Overview
Table 92. Merck and Co. Clinical Biomarker Testing Product
Table 93. Merck and Co. Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 94. Merck and Co. Recent Development
Table 95. Thermofisher Scientific Company Details
Table 96. Thermofisher Scientific Business Overview
Table 97. Thermofisher Scientific Clinical Biomarker Testing Product
Table 98. Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2020-2025) & (US$ Million)
Table 99. Thermofisher Scientific Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Clinical Biomarker Testing Picture
Figure 2. Global Clinical Biomarker Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Biomarker Testing Market Share by Type: 2024 VS 2031
Figure 4. Cancer Features
Figure 5. Metabolism Features
Figure 6. Infectious Disease Features
Figure 7. Cardiology Features
Figure 8. Neurology Features
Figure 9. Immunological Disease Features
Figure 10. Global Clinical Biomarker Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Clinical Biomarker Testing Market Share by Application: 2024 VS 2031
Figure 12. Drug Discovery Case Studies
Figure 13. Nutrigenomics Case Studies
Figure 14. Toxicology Testing Case Studies
Figure 15. Personalized Medicine Case Studies
Figure 16. Functional Genomics Case Studies
Figure 17. Clinical Biomarker Testing Report Years Considered
Figure 18. Global Clinical Biomarker Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Clinical Biomarker Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Clinical Biomarker Testing Market Share by Region: 2024 VS 2031
Figure 21. Global Clinical Biomarker Testing Market Share by Players in 2024
Figure 22. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Clinical Biomarker Testing Revenue in 2024
Figure 24. North America Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 26. United States Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 30. Germany Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Clinical Biomarker Testing Market Share by Region (2020-2031)
Figure 38. China Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 46. Mexico Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Clinical Biomarker Testing Market Share by Country (2020-2031)
Figure 50. Turkey Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Clinical Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Abbott Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 54. AbbVie Inc. Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 55. Adaptive Biotechnologies Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 56. Agilent Technologies Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 57. BD Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 58. Becton Dickinson Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 60. Danaher Corporation Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 61. Merck and Co. Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 62. Thermofisher Scientific Revenue Growth Rate in Clinical Biomarker Testing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232